TENX CIK: 34956

Tenax Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY22 to FY23
millions USD
FY21:
–
FY22:
22.1
FY23:
0
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−32.7
FY22:
11.1
FY23:
−8.23
FY24:
−19.5
FY25:
−56.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−32.4
FY22:
–
FY23:
–
FY24:
−17.6
FY25:
−52.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−32.5
FY22:
–
FY23:
–
FY24:
−17.6
FY25:
−52.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−32.5
FY22:
11.0
FY23:
−7.71
FY24:
−17.6
FY25:
−52.6

All amounts in millions USD Data sources:SEC EDGARTwelve Data